Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis.

Cardiovasc Drugs Ther · 2025 · PMC12116646 · PMID 38165553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Prescribing DOAC in LBW patients with atrial fibrillation showed a trend toward an overall increase in composite outcome by 55% compared to non-low body weight patients or be it with uncertainty around the point estimate (OR 1.55, 95% CI 1.29–1.86, Q = 11.92, I 2 = 26.05%) (Fig. 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.